FDA Withdraws Approval of Four New Drug Applications and Two Abbreviated New Drug Applications from Abbott Laboratories, et al.

Summary

Abbott Laboratories, et al. are having the FDA withdraw approval of four new drug applications and two abbreviated new drug applications due to the drugs no longer being marketed. The FDA is acting on written requests from the applicants.